Stock info Repros Therapeutics Inc | Filter  Basic-Info

Repros Therapeutics Inc

Repros Therapeutics Inc is active in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent over the period 2006-2016. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The past year was a good year for Repros Therapeutics Inc investors

The stock gained over the past 12 months at around 3 percent. The period between August 2011 and August 2016 was a bad period for the investors. The stock lost around 70 percent. Repros Therapeutics Inc's net results between 2011 and 2015 were very fluctuating and moved between -12,49 million dollars and -29,19 million dollars.

The American company didn't pay out any dividends (in the past 5 years).

Repros Therapeutics Inc's balance mostly financed with debt

At the end of 2015 the American company's balance sheet was worth 21,49 million dollars. The total debt was around 2,92 million dollars. This is 13,59 percent of the total balance sheet. The American company's price/earnings-ratio was -8. So the market valued the stock at -8 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 29,64 million dollars. At the end of 2015 the American company had around 24,3 million stocks listed on the exchanges.

All Repros Therapeutics Inc's financial reports are located here. More information about Repros Therapeutics Inc can be found it's website. .